8-K filed May 31, 2023, 7:59 PM ET CIK 0001622879

leadership confidence high sentiment neutral materiality 0.60

Schwazze names President Nirup Krishnamurthy as CEO; founder Justin Dye becomes Chairman

Medicine Man Technologies, Inc.

Justin Dye resigned as CEO (May 24) and Executive Chairman (May 27); becomes non-executive Chairman.
Nirup Krishnamurthy (former President) appointed CEO; $475K salary, $100K bonus, 800K options, 1.6M RSUs.
Dye gets $300K/year Chairman compensation, $350K severance if removed before May 27, 2024 (not for cause); all stock options fully vest.
Succession planned for nearly a year; Krishnamurthy had been President since Oct 2022; strategy continuity in CO/NM markets.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Justin Dye

Executive Chairman of the Board

Medicine Man Technologies, Inc.

Effective: 2023-05-27
Filed: May 31, 2023, 7:59 PM ET

The Company also received notice of Mr. Dye’s resignation as the Executive Chairman of the Board effective May 27, 2023.

Appointed

Nirup Krishnamurthy

Chief Executive Officer

Medicine Man Technologies, Inc.

Effective: 2023-05-24
Filed: May 31, 2023, 7:59 PM ET

On May 24, 2023, the Board appointed Nirup Krishnamurthy, 60, as the Company’s Chief Executive Officer.

Departed

Justin Dye

Chief Executive Officer

Medicine Man Technologies, Inc.

Effective: 2023-05-24
Successor: Nirup Krishnamurthy
Filed: May 31, 2023, 7:59 PM ET

The Company received notice of the resignation of Justin Dye as the Company’s Chief Executive Officer effective May 24, 2023.

Appointed

Justin Dye

Chairman of the Board

Medicine Man Technologies, Inc.

Effective: 2023-05-27
Filed: May 31, 2023, 7:59 PM ET

Effective as of May 27, 2023, the Board accepted Mr. Dye’s resignation as the Executive Chairman of the Board and appointed Mr. Dye as Chairman of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Justin Dye resigned as Executive Chairman of the Board at Medicine Man Technologies, Inc..

Action: resigned
Role: Executive Chairman of the Board

Exact text from the filing

The Company also received notice of Mr. Dye’s resignation as the Executive Chairman of the Board effective May 27, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Nirup Krishnamurthy was appointed as Chief Executive Officer at Medicine Man Technologies, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On May 24, 2023, the Board appointed Nirup Krishnamurthy, 60, as the Company’s Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Justin Dye resigned as Chief Executive Officer at Medicine Man Technologies, Inc..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

The Company received notice of the resignation of Justin Dye as the Company’s Chief Executive Officer effective May 24, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Justin Dye was appointed as Chairman of the Board at Medicine Man Technologies, Inc..

Action: appointed
Role: Chairman of the Board

Exact text from the filing

Effective as of May 27, 2023, the Board accepted Mr. Dye’s resignation as the Executive Chairman of the Board and appointed Mr. Dye as Chairman of the Board.

View on SEC.gov

Source: SEC EDGAR

accession 0001104659-23-066703

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.